NCT04711837View on ClinicalTrials.gov

Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

April 13, 2022

Study Completion Date

April 20, 2022

Conditions
Anesthesia
Interventions
DRUG

HSK3486

HSK3486 for induction of general anesthesia.

DRUG

Propofol

Propofol for induction of general anesthesia.

Trial Locations (13)

10013

New York City Heath and Hospitals, New York

11794

Stony Brook University Hospital, Stony Brook

27599

UNC Health Care System, Chapel Hill

27705

Duke University, Durham

33321

Phoenix Clinical Research, LLC, Tamarac

43210

The Ohio State University Research Foundation, Columbus

60637

The University of Chicago Medicine, Chicago

75093

Plano Surgical Hospital, Plano

77401

HD Research, Bellaire

78229

Endeavor Clinical Trials, LLC, San Antonio

84107

JBR Clinical Research, Salt Lake City

85053

Arizona Research Center, Phoenix

91105

Lotus Clinical Research, LLC, Pasadena

Sponsors
All Listed Sponsors
lead

Haisco-USA Pharmaceuticals, Inc.

INDUSTRY